Friday, September 30, 2022
HomeBusinessmankind pharma ipo: Mankind Pharma files DRHP for Rs 5,500 crore IPO

mankind pharma ipo: Mankind Pharma files DRHP for Rs 5,500 crore IPO

Mankind Pharma, the drugmaker known for Manforce Condoms and Prega News, has submitted its draft red herring prospectus (DRHP) to market regulator Sebi for an initial public offering on Friday. According to bankers, the size of the tender offer is expected to reach Rs 5,500 crore.

The company’s initial public offering includes an offer for the sale of 4 crore shares by the promoters and existing investors.

The offer for sale includes up to 1 crore shares by promoter Juneja Family, up to 2 crore shares by Capital International, up to 99.65 lakh by Beige and up to 50,000 shares by Link Investment Trust.

The ChrysCapital-backed consortium of

of Singapore and CPP Investments own 10% of Mankind, while Capital International still owns an 11% stake.

The company has hired JM Morgan, Citi, Jefferies, Axis, IIFL and Kotak as investment bankers.

The company posted a turnover of about Rs 8,000 crore and an EBITDA of Rs 2,200 crore in FY22.

Mankind’s best over-the-counter brands include Prega News Pregnancy Test Kit, Unwanted-21 Emergency Contraception, AcneStar Antibacterial Gel, Ringout Antifungal Powder, Gas-O-Fast, Kaloree 1 Artificial Sweetener, Heal-O – Kind of Antibacterial Ointment, Addiction Deodorant, and KabzEnd .

This will be one of the biggest public concerns of a domestic drug maker after its Rs 6,480 crore IPO

in 2020. Macleods Pharmaceuticals has also filed to raise Rs 5,000 crore through an initial public offering (IPO), while Pune-based Emcure Pharma is planning an IPO of Rs 4,500 crore.

See also  domestic airfares: No caps on domestic airfares from today; here's what it means for flyers
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments